Palo Alto, CA, United States of America

Sofie Kleppner




Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Sofie Kleppner

Introduction

Sofie Kleppner is a notable inventor based in Palo Alto, California. She has made significant contributions to the field of medical devices, particularly in the treatment of Parkinson's disease. With a total of two patents to her name, her work focuses on innovative solutions that enhance patient care.

Latest Patents

Kleppner's latest patents include an implantable polymeric device designed for the sustained release of dopamine agonists. This invention provides compositions, methods, and kits for treating Parkinson's disease and other conditions where dopamine agonists are therapeutically beneficial. The device is biocompatible and non-erodible, allowing for continuous release of the dopamine agonist with generally linear release kinetics over extended periods. The dopamine agonist is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. This device can be administered subcutaneously to individuals requiring continuous treatment.

Career Highlights

Sofie Kleppner is currently associated with Titan Pharmaceuticals, Inc., where she continues to innovate in the medical device sector. Her work has the potential to significantly improve the quality of life for patients suffering from chronic conditions.

Collaborations

Some of her notable coworkers include Rajesh A Patel and Louis R Bucalo, who contribute to the collaborative environment at Titan Pharmaceuticals, Inc.

Conclusion

Sofie Kleppner's contributions to medical technology, particularly through her innovative patents, highlight her commitment to improving patient outcomes. Her work exemplifies the impact of dedicated inventors in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…